Clinical Research Network Serving Florida
Sponsor / CRO Info
A large network of experienced investigators clinical research facilities, successful patient recruitment and retention strategies, and more.
Therapeutic Areas We Research
Women’s Health, Cardiology, Vaccines, Dermatology, Nephrology, Pediatric Pulmonology, and More!
Clinical Research Blog
Mr. Trump received a single dose of an antibody cocktail made by the biotech company Regeneron. The company’s C.E.O. has known the president for years. President Trump has received a dose of an experimental antibody cocktail being developed by the drug maker Regeneron, in addition to several other drugs, including zinc, vitamin D and the
The Washington Post (9/30, A1, Johnson) reports many experts think a drug, called a monoclonal antibody cocktail, “could be the best bet to defang the novel coronavirus and transform it from a potentially lethal infection into a treatable illness.” NIH Director Francis Collins said it is “a real best chance of being a game changer.” Meanwhile, Janet Woodcock,
A Regeneron Pharmaceuticals Inc. antibody cocktail may help treat coronavirus patients outside of the hospital by reducing virus levels and symptoms, early study results indicate. In an early-stage clinical trial of 275 Covid-19 patients, those who received Regeneron’s experimental therapy had lower virus levels in the bloodstream seven days later compared with patients who received a placebo,